Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 379,803 | reported | 14 Feb 2026 | tx 15+1,043,275−52,679 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2026 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 16,579 | 1.89 USD | |
| 14 Feb 2026 | EXERCISE | C4 Therapeutics, Inc. | 30,950 | 0.00 USD | |
| 13 Feb 2026 | GRANT_AWARD | C4 Therapeutics, Inc. | 240,000 | 0.00 USD | |
| 16 Jan 2026 | SALE | C4 Therapeutics, Inc. | 10,000 | 2.22 USD | |
| 10 Jul 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 7,382 | 1.99 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 5,145 | 3.18 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 87,100 | 0.00 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 130,600 | 0.00 USD | deriv |
| 10 Jul 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 6,191 | 5.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 36,700 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 165,300 | 0.00 USD | deriv |
| 10 Jul 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 61,300 | 0.00 USD | |
| 10 Jul 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 276,000 | 0.00 USD | deriv |